Parallax Volatility Advisers
QTTB icon

Parallax Volatility Advisers’s Q32 Bio QTTB Stock Holding History

Parallax Volatility Advisers’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-886
Closed -$125K – 2401
2021
Q3 		$125K Buy
+886
New +$113K ﹤0.01% 1754

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Parallax Volatility Advisers's QTTB Position: Q4 2021 in Review

Parallax Volatility Advisers sold out of Q32 Bio (QTTB) in Q4 2021, closing a stake of 886 shares — an estimated $125K sold.

Parallax Volatility Advisers first reported a position in QTTB in Q3 2021 and held it in 1 quarter. The position peaked at $125K in Q3 2021. 120 funds tracked by Wall St. Rank hold QTTB as of Q4 2021.

  • Parallax Volatility Advisers reported no remaining Q32 Bio position as of Q4 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 886 Q32 Bio shares in Q4 2021, an estimated $125K.
  • Parallax Volatility Advisers first reported a position in Q32 Bio in Q3 2021 and held it in 1 quarter.
  • Parallax Volatility Advisers's Q32 Bio position peaked at $125K in Q3 2021.
  • 120 funds tracked by Wall St. Rank held Q32 Bio as of Q4 2021.

Based on Parallax Volatility Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.